... Chemotherapy for Acute Myeloid LeukemiaSome of the common chemotherapy drugs used to treat acute myeloid leukemia (AML) include: Cerubidine (daunorubicin) Cytarabine Dacogen (decitabine) Idamycin (idarubicin) Vidaza (azacitidine) People with FLT3 or other genetic mutations may be treated with Rydapt (midostaurin). ...
... Chemotherapy for Acute Myeloid LeukemiaSome of the common chemotherapy drugs used to treat acute myeloid leukemia (AML) include: Cerubidine (daunorubicin) Cytarabine Dacogen (decitabine) Idamycin (idarubicin) Vidaza (azacitidine) People with FLT3 or other genetic mutations may be treated with Rydapt (midostaurin). ...
... Common chemotherapy drugs used to treat AML include: Azacitidine (Onureg) combined with venetoclax (Venclexta) Cytarabine Daunorubicin Decitabine (Dacogen) combined with venetoclax Fludarabine phosphate Idarubicin (Idamycin PFS) In contrast, chemotherapy is rarely used to treat CML because targeted therapy tends to work better. ...
... Common chemotherapy drugs used to treat AML include: Azacitidine (Onureg) combined with venetoclax (Venclexta) Cytarabine Daunorubicin Decitabine (Dacogen) combined with venetoclax Fludarabine phosphate Idarubicin (Idamycin PFS) In contrast, chemotherapy is rarely used to treat CML because targeted therapy tends to work better. ...
... They include: Vidaza (azacitidine) Dacogen (decitabine) Inqovi (decitabine and cedazuridine) Chemotherapy drugs don’t cure CMML. However, they may normalize blood cell counts, which may help reduce symptoms. Treatments for the SpleenCMML may make the spleen grow very large. ...
... They include: Vidaza (azacitidine) Dacogen (decitabine) Inqovi (decitabine and cedazuridine) Chemotherapy drugs don’t cure CMML. However, they may normalize blood cell counts, which may help reduce symptoms. Treatments for the SpleenCMML may make the spleen grow very large. ...
... The combination of decitabine and cedazuridine is approved for people with intermediate- or high-risk disease who have chronic myelomonocytic leukemia (or CMML) or the following types of MDS: Refractory anemia Refractory anemia with ringed sideroblasts Refractory anemia with excess blasts Decitabine (sold as Dacogen) has been given to people with MDS ...
... The combination of decitabine and cedazuridine is approved for people with intermediate- or high-risk disease who have chronic myelomonocytic leukemia (or CMML) or the following types of MDS: Refractory anemia Refractory anemia with ringed sideroblasts Refractory anemia with excess blasts Decitabine (sold as Dacogen) has been given to people with MDS ...
... (filgrastim or granulocyte colony-stimulating factor), Neulasta (pegfilgrastim), or Leukine (sargramostim or granulocyte macrophage-colony stimulating factor) Platelet growth factors include Nplate (romiplostim), Promacta (eltrombopag), or Neumega (oprelvekin or interleukin-11) ChemotherapyMany people with MDS use chemotherapy medication such as: Dacogen ...
... (filgrastim or granulocyte colony-stimulating factor), Neulasta (pegfilgrastim), or Leukine (sargramostim or granulocyte macrophage-colony stimulating factor) Platelet growth factors include Nplate (romiplostim), Promacta (eltrombopag), or Neumega (oprelvekin or interleukin-11) ChemotherapyMany people with MDS use chemotherapy medication such as: Dacogen ...